Radiopharmaceuticals: a year of breakthroughs and record growth

Pharma giants, biotech innovators, and investors are rapidly converging on radiopharmaceuticals, drawn by a wave of clinical breakthroughs, blockbuster sales, and rising demand for targeted cancer care. Dr Leonid Shapiro, managing partner, and Dr Nicolas Correa, engagement manager, from Candesic, examine how this once-niche field is now commanding global attention The radiopharmaceutical industry has seen…